Medical Director, Oncology Clinical Development

Sumitomo Pharma; Des Moines (IA); Remote; USD 226,000 - 282,000; Full time

Job summary

Sumitomo Pharma America, Inc. in the United States is seeking an Associate Medical Director, Clinical Development – Oncology to lead trial design, execution, and interpretation for novel oncology compounds from early development through global regulatory submissions.

This senior role emphasizes hematologic malignancies, cross-functional collaboration, and scientific leadership in study teams, with remote work and periodic on-site meetings to support global programs.

Qualifications

• MD/DO or non-US equivalent.
• Residency completion strongly preferred.
• Subspecialty fellowship desirable.
• Experience in hematologic malignancies or solid tumors desirable.
• 0 to 3 years of pharmaceutical drug development experience required.

Responsibilities

• Lead design and interpretation of clinical protocols and studies.
• Provide clinical input to regulatory documents and publications.
• Manage study teams and ensure data integrity and safety oversight.
• Present at scientific, medical, and regulatory meetings globally.
• Develop relationships with investigators, partners, and KOLs.
• Contribute to regulatory filings (INDs, NDAs) and translational strategies.

Skills

Clinical trial design

Hematologic malignancies

Leadership

Regulatory & compliance

Communication

Cross-functional collaboration

Education

MD/DO or non-US MD equivalent

Residency completion preferred

Subspecialty fellowship desirable

Experience in blood cancers or solid tumors desirable

Job description

Sumitomo Pharma America, Inc. in the United States is seeking an Associate Medical Director, Clinical Development – Oncology to lead trial design, execution, and interpretation for novel oncology compounds from early development through global regulatory submissions.

This senior role emphasizes hematologic malignancies, cross-functional collaboration, and scientific leadership in study teams, with remote work and periodic on-site meetings to support global programs.